iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Shares Down 1.3% – Time to Sell?

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) fell 1.3% during mid-day trading on Monday . The company traded as low as $25.43 and last traded at $25.50. 1,121 shares traded hands during mid-day trading, an increase of 73% from the average session volume of 647 shares. The stock had previously closed at $25.83.

iShares Neuroscience and Healthcare ETF Trading Down 0.4 %

The company’s 50-day moving average is $26.61 and its 200 day moving average is $25.61. The firm has a market cap of $3.81 million, a PE ratio of 28.31 and a beta of 1.06.

Institutional Investors Weigh In On iShares Neuroscience and Healthcare ETF

A hedge fund recently bought a new stake in iShares Neuroscience and Healthcare ETF stock. Jane Street Group LLC bought a new position in shares of iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 10,150 shares of the company’s stock, valued at approximately $254,000. Jane Street Group LLC owned 6.77% of iShares Neuroscience and Healthcare ETF as of its most recent SEC filing.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.